When and for whom should we consider adding bempedoic acid to the lipid lowering regimen?

Bemepedoic acid is approved in the US for use as an adjunct to statin therapy in patients with established ASCVD (secondary prevention) or those with heterozygous Familial Hypercholesterolemia who require additional LDL- cholesterol reduction. More recently it has also been approved for primary prev...

The cost of adding these medications is prohibitive. Yes, it is true of the added benefit on top of statin just like PCSK9 inhibitors and Inclisiran. However, do we assume that our patients have unlimited financial resources! The incremental added value is smaller when added as an adjunctive as comp...

By the way, Canadian drug stores make it affordable.